Evidence map›Paper›PMID 34814846›Full record

ArticleBMC gastroenterology2021

Patient preferences of healthcare delivery in irritable bowel syndrome: a focus group study.

Gwen M C Masclee, Johanna T W Snijkers, Marijke Boersma, Ad A M Masclee, Daniel Keszthelyi

Abstract read
In one paragraph

Article in BMC gastroenterology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Gwen M C MascleeDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Maastricht University Medical Center +, PO Box 5800, 6202 AZ, Maastricht, The Netherlands.
Johanna T W SnijkersDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Maastricht University Medical Center +, PO Box 5800, 6202 AZ, Maastricht, The Netherlands.
Marijke BoersmaDutch Foundation of Gastroenterology and Hepatology (Maag Lever Darm Stichting), Amersfoort, The Netherlands.
Ad A M MascleeDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Maastricht University Medical Center +, PO Box 5800, 6202 AZ, Maastricht, The Netherlands.
Daniel KeszthelyiDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Maastricht University Medical Center +, PO Box 5800, 6202 AZ, Maastricht, The Netherlands. daniel.keszthelyi@maastrichtuniversity.nl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIrritable bowel syndrome (IBS) is a highly prevalent disorder with significant negative impact on quality of life of patients that results in high healthcare use and costs. Improving healthcare outcomes for IBS patients is warranted, however the exact needs of IBS patients with regard to therapy and control of symptoms are unknown.

methodsFocus group interviews, using a two-stage model, were performed with twenty-three IBS patients meeting Rome III criteria and one mother of a patient, from four different regions from the Netherlands.

resultsTwenty-four participants were included of whom majority were female (n = 21), mean age was 43 years, and mean duration of IBS was 18 years. Five categories of patients' perspectives were identified: clear communication, a multidisciplinary treatment team, centers of expertise, focus on scientific research and information about IBS that is widely available for patients.

conclusionsBased on these findings we highlight the need for IBS care givers to take these key items into account in IBS care. These elements aid clinicians, but mostly patients, in coping and management of symptoms and subsequent healthcare outcomes, reducing overall healthcare use and costs.

Indexed as

Irritable Bowel SyndromeAdultFemaleFocus GroupsHumansMaleNetherlandsPatient PreferenceQuality of LifeFocus groupIrritable bowel syndromePatient preferenceTherapyTreatment

Identifiers

PMID34814846
PMCPMC8609738

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.